The value of maintenance therapy in intermediate‐risk non‐muscle‐invasive bladder cancer

The IBCG algorithm effectively stratifies patients with IR-NMIBC by recurrence risk. In this observational cohort, maintenance therapy was associated with lower recurrence rates in patients with one to two or three or more IBCG risk factors, but not in those with no risk factors. These findings suggest that the IBCG stratification may inform risk-adapted treatment decisions in patients with IR-NMIBC.

Authors

Institutions

Publication Details

Journal
British Journal of Urology
Published
2025-08-22
DOI
https://doi.org/10.1111/bju.16905
Citations
2
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
4.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The value of maintenance therapy in intermediate‐risk non‐muscle‐invasive bladder cancer

Leonardo Quarta, Pietro Scilipoti, Andrea Salonia, Mattia Longoni et al.
2 citations
British Journal of Urology
Bladder and Urothelial Cancer Treatments
4.01
article

The value of maintenance therapy in intermediate‐risk non‐muscle‐invasive bladder cancer

Leonardo Quarta, Pietro Scilipoti, Andrea Salonia, Mattia Longoni, Alessandro Viti, Andrea Cosenza, Natasha Disabato, Marco Moschini, Francesco Montorsi, Mario de Angelis, Gemma Tremolada, Giusy Burgio, Alfonso Santangelo, Andrea Necchi, Maurizio Colecchia, Paolo Zaurito, Michele Brancaccio, Alberto Briganti, Armando Galdieri, Angelo Occhi
article en
2 citations

Abstract

The IBCG algorithm effectively stratifies patients with IR-NMIBC by recurrence risk. In this observational cohort, maintenance therapy was associated with lower recurrence rates in patients with one to two or three or more IBCG risk factors, but not in those with no risk factors. These findings suggest that the IBCG stratification may inform risk-adapted treatment decisions in patients with IR-NMIBC.

British Journal of UrologyVol. 137(1)
Vita-Salute San Raffaele University (IT), Zero to Three (US), IRCCS Ospedale San Raffaele (IT)
Openalex Percentile: Top 6%
Bladder and Urothelial Cancer Treatments
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The value of maintenance therapy in intermediate‐risk non‐muscle‐invasive bladder cancer — Leonardo Quarta, Pietro Scilipoti, et al. · British Journal of Urology (2025) | TGRS Research Map | TGRS